Glimirin M 1/500mg Tablet PR 10s

Unsafe: Avoid consuming alcohol with Glimirin M 1mg/500mg Tablet PR as it is deemed unsafe.Unsafe: Avoid consuming alcohol with Glimirin M 1mg/500mg Tablet PR as it is deemed unsafe.

Glimirin M 1mg/500mg Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.Glimirin M 1mg/500mg Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.

Glimirin M 1mg/500mg Tablet PR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.Glimirin M 1mg/500mg Tablet PR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Glimirin M 1mg/500mg Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Glimirin M 1mg/500mg Tablet PR may be needed. Doctor consultation is advised.Use of Glimirin M 1mg/500mg Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.Glimirin M 1mg/500mg Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Glimirin M 1mg/500mg Tablet PR may be needed. Doctor consultation is advised.Use of Glimirin M 1mg/500mg Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Glimirin M 1mg/500mg Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Glimirin M 1mg/500mg Tablet PR may be needed. Doctor consultation is advised.Glimirin M 1mg/500mg Tablet PR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.Glimirin M 1mg/500mg Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Glimirin M 1mg/500mg Tablet PR may be needed. Doctor consultation is advised.Glimirin M 1mg/500mg Tablet PR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.